Small-Vessel Vasculitis: Tx-Related Cancers Falling: The use of cyclophosphamide-sparing regimens ‘might have started to show a benefit.’

The abstract is here.

What I have to say: Cyclophosphamide, although saves WG patients from death, it also has dangers of its own. Many patients who have had to take this medication find that they are at risk for cancer. The new drugs like Rituxan, Imuran, and Methotrexate are less dangerous to the patient in the long-term. However, if the patient has a really bad case of Vasculitis, then Cyclophosphamide may be the only short-term solution.


About Cyn Bagley

My life is a mixture of travel, jobs, and disease. You can find some of my novels on under the name Cyn Bagley.
This entry was posted in cytoxan, Rheumatology, Vasculitis. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s